So am I and the reason for that is due to the fact that ALL of these trials have already been successful in a less formal format. Now I imagine that IHL will tweak the formulations in search of even better results - not selling a single share, IHL will be the success story of 2020.
Ann: IHL Files Patent over IHL-42X for OSA, page-77
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)